Stock Updates

Today’s Top Gainers in the Market Boston Scientific Corporation (NYSE:BSX) from Healthcare

Today’s top gainers include the company Boston Scientific Corporation (NYSE:BSX) which is in the industry Medical Appliances & Equipment, gaining 2.15% today. In the last week its performance is 0.38%, and 1.67% for the past quarter. Currently, Boston Scientific Corporation, BSX has a target price of *TBA, so today’s gain of 2.15% is a significant step towards its target price. The GAP today is therefore 0.21%.

Boston Scientific Corporation (NYSE:BSX), has a market cap of 32306.12, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 94.10%.

At the current price of 23.8, it has a dividend yield of *TBA, and its target price is *TBA. This is with a profit margin of -4.30%, and total debt/equity of 0.87. Boston Scientific Corporation (NYSE:BSX) has a P/E of *TBA, as well as a forward P/E of 18.87.

With a current EPS of -0.26, and a forecasted EPS growth for next year at 14.53%,Boston Scientific Corporation (NYSE:BSX) has had a EPS growth for the past five years at 24.00%. For the next five years EPS growth is projected to be 12.75%.

Performance for the year is 42.60%. Since its IPO date on 5/19/1992, the total performance to date is 29.07%.

Volume today for Boston Scientific Corporation (NYSE:BSX), is 8659100, while its average volume is 8075.16. Whilst the total gain today was 2.15%, it did have a day high of -3.99%.

Volatility for this week has been at 1.89%, and 1.84% for the month. The 52-week low for Boston Scientific Corporation, BSX has been 51.88%, while the 52-week-high has reached -3.99%.

Looking at its return of investments, which is 0.70%, and its return on assets is -1.90%. Boston Scientific Corporation (NYSE:BSX) has an operating margin of -7.70%. With a sales growth of 15.40% quarter over quarter. Bearing in mind that Boston Scientific Corporation, BSX is in the sector Healthcare, its long-term debt/equity is 0.83, and has a current ratio of 1 and 0.7 for quick ratio.

So what is the value of Boston Scientific Corporation? Well its PEG is *TBA, and the P/S is 4.06, along with a P/B of 5.2. Meanwhile it has a p/cash of 73.76.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment